CA3035409C - Gomme a macher en tablette contenant des cannabinoides ayant des plas tifiants elastomeres de poly(acetate de vinyle) - Google Patents

Gomme a macher en tablette contenant des cannabinoides ayant des plas tifiants elastomeres de poly(acetate de vinyle) Download PDF

Info

Publication number
CA3035409C
CA3035409C CA3035409A CA3035409A CA3035409C CA 3035409 C CA3035409 C CA 3035409C CA 3035409 A CA3035409 A CA 3035409A CA 3035409 A CA3035409 A CA 3035409A CA 3035409 C CA3035409 C CA 3035409C
Authority
CA
Canada
Prior art keywords
chewing gum
gum composition
composition according
tableted chewing
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3035409A
Other languages
English (en)
Other versions
CA3035409A1 (fr
Inventor
Heidi Ziegler Bruun
Dorthe Schackinger Boesen
Ane Eriksen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordiccan AS
Original Assignee
Nordiccan AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA3035409A priority Critical patent/CA3035409C/fr
Application filed by Nordiccan AS filed Critical Nordiccan AS
Priority to PCT/DK2019/050307 priority patent/WO2020177818A1/fr
Priority to JP2021547493A priority patent/JP7531500B2/ja
Priority to EP19805886.9A priority patent/EP3876916B1/fr
Priority to AU2019432305A priority patent/AU2019432305B2/en
Priority to CN201980090207.3A priority patent/CN113329743B/zh
Priority to DK19805886.9T priority patent/DK3876916T3/da
Publication of CA3035409A1 publication Critical patent/CA3035409A1/fr
Application granted granted Critical
Publication of CA3035409C publication Critical patent/CA3035409C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Confectionery (AREA)

Abstract

La présente invention concerne une composition de gomme à mâcher en comprimés pour ladministration orale de cannabinoïdes, la composition comprenant des ingrédients de gomme à mâcher solubles dans leau et une base de gomme insoluble dans leau située dans une pluralité de particules, où une première population de particules comprend une base de gomme insoluble dans leau, comprenant un ou plusieurs plastifiants élastomères dacétate de polyvinyle, et une seconde population de particules comprend des ingrédients de gomme à mâcher solubles dans leau, la seconde population de particules étant exempte de base de gomme insoluble dans leau, où la composition de gomme à mâcher comprend un ou plusieurs cannabinoïdes.
CA3035409A 2019-03-01 2019-03-01 Gomme a macher en tablette contenant des cannabinoides ayant des plas tifiants elastomeres de poly(acetate de vinyle) Active CA3035409C (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA3035409A CA3035409C (fr) 2019-03-01 2019-03-01 Gomme a macher en tablette contenant des cannabinoides ayant des plas tifiants elastomeres de poly(acetate de vinyle)
JP2021547493A JP7531500B2 (ja) 2019-03-01 2019-10-10 ポリ酢酸ビニルエラストマー可塑剤を含む打錠カンナビノイドチューインガム
EP19805886.9A EP3876916B1 (fr) 2019-03-01 2019-10-10 Gomme à mâcher cannabinoïde en comprimés avec des plastifiants élastomères d'acétate de polyvinyle
AU2019432305A AU2019432305B2 (en) 2019-03-01 2019-10-10 Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
PCT/DK2019/050307 WO2020177818A1 (fr) 2019-03-01 2019-10-10 Gomme à mâcher cannabinoïde en comprimés avec des plastifiants élastomères d'acétate de polyvinyle
CN201980090207.3A CN113329743B (zh) 2019-03-01 2019-10-10 具有聚乙酸乙烯酯弹性体增塑剂的压片大麻素口香糖
DK19805886.9T DK3876916T3 (da) 2019-03-01 2019-10-10 Tabletteret cannabinoidtyggegummi med polyvinylacetatelastomerblødgøringsmidler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3035409A CA3035409C (fr) 2019-03-01 2019-03-01 Gomme a macher en tablette contenant des cannabinoides ayant des plas tifiants elastomeres de poly(acetate de vinyle)

Publications (2)

Publication Number Publication Date
CA3035409A1 CA3035409A1 (fr) 2020-01-20
CA3035409C true CA3035409C (fr) 2021-05-11

Family

ID=69178175

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3035409A Active CA3035409C (fr) 2019-03-01 2019-03-01 Gomme a macher en tablette contenant des cannabinoides ayant des plas tifiants elastomeres de poly(acetate de vinyle)

Country Status (1)

Country Link
CA (1) CA3035409C (fr)

Also Published As

Publication number Publication date
CA3035409A1 (fr) 2020-01-20

Similar Documents

Publication Publication Date Title
CA3031530C (fr) Gomme a macher contenant des cannabinoides avec alcools de sucre
US12582602B2 (en) Tableted cannabinoid chewing gum with tableted modules
US10933017B2 (en) Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
AU2019432305B2 (en) Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
AU2019432306B2 (en) Tableted cannabinoid chewing gum with layered structure
US11471405B2 (en) Tableted chewing gum with enhanced delivery of cannabinoids
US11253473B2 (en) Method of producing tableted cannabinoid chewing gum
CA3035409C (fr) Gomme a macher en tablette contenant des cannabinoides ayant des plas tifiants elastomeres de poly(acetate de vinyle)
CA3035400C (fr) Gomme a macher en tablette contenant des cannabinoides en couches
CA3035381C (fr) Gomme a macher en tablette contenant des cannabinoides avec liberati on amelioree
AU2019433058B2 (en) Tableted cannabinoid chewing gum with improved release
EP3930473B1 (fr) Procédé de production d'une gomme à mâcher à base de cannabinoïdes en comprimés
CA3035417C (fr) Methode de production de gomme a macher en tablette contenant des can nabinoides
CA3035390C (fr) Gomme a macher en tablette avec administration amelioree de cannabin oides
CA3031500C (fr) Gomme a macher contenant des cannabinoides avec edulcorants a inten site elevee
CA3031499C (fr) Gomme a macher contenant des cannabinoides ayant des plastifiants el astomeres de poly(acetate de vinyle)
US20200276118A1 (en) Tableted cannabinoid chewing gum with improved release
EP3930696A1 (fr) Gomme à mâcher en comprimés à administration améliorée de cannabinoïdes
CA3031519A1 (fr) Gomme a macher contenant des cannabinoides avec liberation amelioree de cannabinoides

Legal Events

Date Code Title Description
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250221

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250224